ICS/LABA Adherence and COPD Exacerbation

Trial Identifier:	D589BR00034
Sponsor:	AstraZeneca
Collaborator:	Healthcore
NCTID::	NCT02446041
Start Date:	May 2015
Primary Completion Date:	October 2015
Study Completion Date:	October 2015
Condition:	Other; Immune, Inflammatory & Infections - Other

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
USA, DE	Wilmington, DE, USA

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.